Article
G2385R and I2020T Mutations Increase LRRK2 GTPase Activity.
BioMed research international - 1 Jan 2016
Ho Dong Hwan, Jang Jihoon, Joe Eun-Hye, Son Ilhong, Seo Hyemyung, Seol Wongi
Abstract excerpt
The LRRK2 mutation is a major causal mutation in familial Parkinson's disease. Although LRRK2 contains functional GTPase and kinase domains and their activities are altered by pathogenic mutations, most studies focused on LRRK2 kinase activity because the most prevalent mutant, G2019S, enhances kinase activity. However, the G2019S mutation is extremely rare in the Asian population. Instead, the G2385R mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
